Pharmacogenomics : (Record no. 26730)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02111cam a2200241 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 030502s2003 xxu eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0471227692 |
| 035 ## - | |
| -- | (Sirsi) i0471227692 |
| 060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
| Classification number | QV 38 2003PH |
| 245 00 - TITLE STATEMENT | |
| Title | Pharmacogenomics : |
| Remainder of title | social, ethical, and clinical dimensions / |
| Statement of responsibility, etc. | edited by Mark A. Rothstein. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc. | Hoboken, N.J. : |
| Name of publisher, distributor, etc. | Wiley-Liss, |
| Date of publication, distribution, etc. | 2003. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 368 p. |
| 505 ## - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Public attitudes about pharmacogenomics / Mark A. Rothstein and Carlton A. Hornung -- Pharmacogenomics:pharmacology and toxicology in the genomics era / Harvey W. Mohrenweiser -- The implications of population genetics for pharmacogenomics / Craig L.Hanis -- Genome research and minorities / Henry T. Greely -- Drug development strategies / Penelope K. Manasco and Teresa E. Arledge -- Drug development, regulation, and genetically guided therapy / David W. Feigal and Steven I. Gutman -- Intellectual property and commercial aspects of pharmacogenomics / Allen C. Nunnally, Scott A. Brown, and Gary A. Cohen -- Integration of pharmacogenomics into medical practice / Gilbert S. Omenn and Arno G. Motulsky - - Clinical utility of pharmacogenetics and pharmacogenomics / Neil A. Holtzman -- Medical liability for pharmacogenomics -- Larry I. Palmer -- The challenges of pharmacogenomics for pharmacy education / David B. Brushwood -- Economic implications of pharmacogenomics / C.E. Reeder and W. Michael Dickson -- Pharmacogenomics and the social construction of identity / Morris W. Foster -- Pharmacogenomics: considerations for communities of color / Laurie Nsiah-Jefferson -- Constitutional issues in the use of pharmacogenomic variations associated with race / John A. Robertson |
| 596 ## - | |
| -- | 4 |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Pharmacogenetics. |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Drug design |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Ethics, Medical. |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Legislation, Medical. |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Public policy. |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Social environment. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rothstein, Mark A . |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | NLM Classification Scheme |
| Koha item type | Books |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Shelving location | Date acquired | Permanent Item | Total Checkouts | Full call number | Barcode | Date last seen | Copy number | Bill Date | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NLM Classification Scheme | WHO HQ | WHO HQ | BORROWABLE-COLL-STACKS | 02/05/2003 | Y | QV 38 2003PH | 00077816 | 12/09/2016 | 1 | 12/09/2016 | Books |